InsidersTradesSigma
Discover the detailed record of transactions filed by Notman Donald, Chief Financial Officer. Director active across 2 companies, notably OCULAR THERAPEUTIX, INC. In total, 2 disclosures have been recorded. The latest transaction was filed on 3 February 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Donald Notman is the Chief Financial Officer at Ocular Therapeutix, Inc. He is responsible for the financial management of the company, including financial planning and performance analysis. His expertise in finance is essential to support the company's strategic goals.